White House After 7 months at NCI, Bertagnolli is about to be named NIH director April 21, 2023Vol.49 No.16By Paul Goldberg
White House Decline in cancer mortality rate must accelerate to reach Moonshot goal, NCI study finds April 21, 2023Vol.49 No.16By Jacquelyn Cobb
FreeObituary Leon Levine: Philanthropist, businessman, NFL owner, proud Jewish citizen, dies at 85 April 21, 2023Vol.49 No.16By Derek Raghavan
Guest Editorial CPRIT leaders: Texas ruling that curbs USPSTF authority threatens progress against cancer April 21, 2023Vol.49 No.16By Michelle M. Le Beau, Ramona Magid and Patty Moore
FreeIn the Archives The President’s Cancer Panel: 50 years of charting policy April 21, 2023Vol.49 No.16
Conversation with The Cancer LetterFree Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program April 14, 2023Vol.49 No.15By Paul Goldberg and Matthew Bin Han Ong
Trials & Tribulations San Antonio Breast Cancer Symposium 2022 tackled big obstacles, recommended solutions for breast cancer progress April 14, 2023Vol.49 No.15By Angela DeMichele, Rajarshi Sengupta and Carlos L. Arteaga
Guest Editorial Mifepristone and the Administrative Procedure Act: Perspective of a former FDA commissioner and NCI director April 14, 2023Vol.49 No.15By Norman E. "Ned" Sharpless
Conversation with The Cancer LetterJudiciary Bipartisan Policy Center’s Anand Parekh: Rulings on USPSTF, mifepristone are ideological threats to evidence-based care April 14, 2023Vol.49 No.15By Matthew Bin Han Ong
Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment April 14, 2023Vol.49 No.15By Jacquelyn Cobb
